Sign up to save your podcasts
Or
Share JAMA Oncology : Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
More shows like JAMA Network
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
317 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
498 Listeners
Medicine and Science from The BMJ
35 Listeners
Diabetes Core Update
105 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
12 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
7 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
JAMAevidence The Rational Clinical Examination
30 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
370 Listeners
NEJM AI Grand Rounds
60 Listeners